Solvay (SOLB) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
22 Jan, 2026Executive summary
2024 marked a pivotal year with a successful spinoff, solid results, and a more focused, agile organization, despite challenging market conditions.
Achieved underlying EBITDA of €1,052 million, exceeding guidance, with strong cost savings of €110 million, and resilient free cash flow of €361 million.
Launched the 'For Generations' sustainability roadmap, targeting carbon neutrality by 2050, enhanced biodiversity, and new diversity commitments.
Advanced energy transition projects, including coal phase-out at key sites and a biomass project in Spain.
Safety culture transformation initiated after three contractor fatalities, with a dedicated Group Safety team established.
Financial highlights
Full year 2024 underlying net sales: €4,686 million, down 4% organically year-over-year; Q4 net sales up 0.5% organically.
Underlying EBITDA: €1,052 million, down 8.2% organically but above guidance; margin at 22.5%.
Free cash flow to shareholders: €361 million, with a conversion ratio of 34.6%.
Capex for 2024: €355 million.
Net financial debt stable at €1.5 billion; leverage ratio 1.5x EBITDA.
Proposed gross dividend: €2.43 per share for 2024, well covered by free cash flow.
Outlook and guidance
2025 underlying EBITDA expected between €1.0 billion and €1.1 billion; free cash flow around €300 million; capex projected at €300–350 million.
Cost savings target raised to €200 million for 2025, with a run-rate of €350 million by 2028.
2028 targets reaffirmed: mid single-digit annual EBITDA growth, margin and ROCE targets, and no significant new investments needed.
Latest events from Solvay
- Strong 2025 results with robust cash flow, cost savings, and accelerated sustainability initiatives.SOLB
Roadshow presentation6 Mar 2026 - 2025 delivered strong cash flow and margins; 2026 outlook cautious with EBITDA €770–850m.SOLB
Q4 202524 Feb 2026 - Sequential EBITDA and margin gains offset year-over-year declines, with guidance upgraded.SOLB
Q2 20242 Feb 2026 - Q3 2024 delivered resilient sales and EBITDA, with guidance confirmed at the high end.SOLB
Q3 202422 Jan 2026 - Q3 sales and EBITDA fell 7%, but margins, cash flow, and guidance remained robust.SOLB
Q3 202522 Jan 2026 - Q1 2025 sales and EBITDA fell 6%, but margins held and 2025 guidance is reaffirmed.SOLB
Q1 202522 Jan 2026 - Q2 2025 sales and EBITDA fell on soft demand, but margins and cash flow stayed resilient.SOLB
Q2 202522 Jan 2026 - Operational excellence, sustainability, and resilient financials drive ongoing transformation.SOLB
AGM 2025 Presentation2 Jul 2025